Search Results - "KAMPIK, ANSELM"

Refine Results
  1. 1
  2. 2

    Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes by Stalmans, Peter, Benz, Matthew S, Gandorfer, Arnd, Kampik, Anselm, Girach, Aniz, Pakola, Stephen, Haller, Julia A

    Published in The New England journal of medicine (16-08-2012)
    “…Vitreolysis for Vitreomacular Traction and Macular Holes Intravitreal injection of a modified protease that targets components of the vitreomacular interface…”
    Get full text
    Journal Article
  3. 3

    Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay by Messmer, Elisabeth M., MD, FEBO, von Lindenfels, Victoria, MS, Garbe, Alexandra, MS, Kampik, Anselm, MD, FEBO

    Published in Ophthalmology (Rochester, Minn.) (01-11-2016)
    “…Purpose To measure matrix metalloproteinase 9 (MMP-9) in the tear film of patients with dry eye disease (DED) compared with controls and to correlate clinical…”
    Get full text
    Journal Article
  4. 4

    Efficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion by Haller, Julia A., MD, Stalmans, Peter, MD, PhD, Benz, Matthew S., MD, Gandorfer, Arnd, MD, Pakola, Stephen J., MD, Girach, Aniz, MD, Kampik, Anselm, MD, Jaffe, Glenn J., MD, Toth, Cynthia A., MD

    Published in Ophthalmology (Rochester, Minn.) (2015)
    “…Purpose To evaluate the efficacy of a single intravitreal injection of ocriplasmin 125 μg across relevant subpopulations of patients with symptomatic…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Lamellar Hole–Associated Epiretinal Proliferation in Comparison to Epiretinal Membranes of Macular Pseudoholes by Compera, Denise, Entchev, Enrico, Haritoglou, Christos, Scheler, Renate, Mayer, Wolfgang J, Wolf, Armin, Kampik, Anselm, Schumann, Ricarda G

    Published in American journal of ophthalmology (01-08-2015)
    “…Purpose To compare immunocytochemical and ultrastructural characteristics of “lamellar hole–associated epiretinal proliferation” in lamellar macular holes with…”
    Get full text
    Journal Article
  7. 7

    Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema by Haritoglou, Christos, Kook, Daniel, Neubauer, Aljoscha, Wolf, Armin, Priglinger, Siegfried, Strauss, Rupert, Gandorfer, Arnd, Ulbig, Michael, Kampik, Anselm

    Published in Retina (Philadelphia, Pa.) (01-11-2006)
    “…To evaluate the efficacy of bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA) for the treatment of diabetic macular edema. This prospective,…”
    Get full text
    Journal Article
  8. 8

    Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expression by Liegl, Raffael, Koenig, Susanna, Siedlecki, Jakob, Haritoglou, Christos, Kampik, Anselm, Kernt, Marcus

    Published in PloS one (26-02-2014)
    “…Due to their high prevalence, retinal vascular diseases including age related macular degeneration (AMD), retinal vein occlusions (RVO), diabetic retinopathy…”
    Get full text
    Journal Article
  9. 9

    Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales by Wilkinson, C P, Ferris, 3rd, Frederick L, Klein, Ronald E, Lee, Paul P, Agardh, Carl David, Davis, Matthew, Dills, Diana, Kampik, Anselm, Pararajasegaram, R, Verdaguer, Juan T

    Published in Ophthalmology (Rochester, Minn.) (01-09-2003)
    “…To develop consensus regarding clinical disease severity classification systems for diabetic retinopathy and diabetic macular edema that can be used around the…”
    Get more information
    Journal Article
  10. 10

    Residual cellular proliferation on the internal limiting membrane in macular pucker surgery by Gandorfer, Arnd, Haritoglou, Christos, Scheler, Renate, Schumann, Ricarda, Zhao, Fei, Kampik, Anselm

    Published in Retina (Philadelphia, Pa.) (01-03-2012)
    “…To provide pathology data on the completeness of epiretinal membrane (ERM) removal with and without internal limiting membrane (ILM) peeling. Twenty-two…”
    Get full text
    Journal Article
  11. 11

    Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema by Liegl, Raffael, Langer, Julian, Seidensticker, Florian, Reznicek, Lukas, Haritoglou, Christos, Ulbig, Michael W, Neubauer, Aljoscha S, Kampik, Anselm, Kernt, Marcus

    Published in PloS one (26-12-2014)
    “…To evaluate if a standardized combination therapy regimen, utilizing 3 monthly ranibizumab injections followed by navigated laser photocoagulation, reduces the…”
    Get full text
    Journal Article
  12. 12

    Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction by Kaiser, Peter K, Kampik, Anselm, Kuppermann, Baruch D, Girach, Aniz, Rizzo, Stanislao, Sergott, Robert C

    Published in Retina (Philadelphia, Pa.) (01-06-2015)
    “…To report the safety of intravitreal ocriplasmin injection based on 2 Phase 3 clinical trials in patients with symptomatic vitreomacular adhesion/vitreomacular…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Laser, intravitreal drug application, and surgery to treat diabetic eye disease by Kampik, Anselm

    Published in Oman journal of ophthalmology (01-12-2013)
    “…[4] Most persons, health professionals and lay-people alike, are not aware how frequently this metabolic disease affects eye sight. [...]diabetic patients are…”
    Get full text
    Journal Article
  15. 15

    Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy by Haritoglou, Christos, Kernt, Marcus, Neubauer, Aljoscha, Gerss, Joachim, Oliveira, Carlos Manta, Kampik, Anselm, Ulbig, Michael

    Published in Retina (Philadelphia, Pa.) (01-01-2014)
    “…To evaluate the predictive value of microaneurysm (MA) formation rate concerning the development of clinically significant macular edema (CSME) in patients…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The Protective Effect of Quercetin against Oxidative Stress in the Human RPE In Vitro by Kook, Daniel, Wolf, Armin H, Yu, Alice L, Neubauer, Aljoscha S, Priglinger, Siegfried G, Kampik, Anselm, Welge-Lussen, Ulrich C

    “…To investigate the possible protective effect of the dietary antioxidant quercetin on retinal pigment epithelial (RPE) cell dysfunction and cellular senescence…”
    Get full text
    Journal Article
  18. 18

    Retinal Damage from Indocyanine Green in Experimental Macular Surgery by Gandorfer, Arnd, Haritoglou, Christos, Gandorfer, Achim, Kampik, Anselm

    “…Previous work has shown that indocyanine green (ICG)-assisted peeling of the inner limiting membrane (ILM) may cause retinal damage. In this study, a toxic and…”
    Get full text
    Journal Article
  19. 19

    Odorant Receptor 51E2 Agonist β-ionone Regulates RPE Cell Migration and Proliferation by Jovancevic, Nikolina, Khalfaoui, Soumaya, Weinrich, Markus, Weidinger, Daniel, Simon, Annika, Kalbe, Benjamin, Kernt, Marcus, Kampik, Anselm, Gisselmann, Günter, Gelis, Lian, Hatt, Hanns

    Published in Frontiers in physiology (30-11-2017)
    “…The odorant receptor 51E2 (OR51E2), which is well-characterized in prostate cancer cells and epidermal pigment cells, was identified for the first time as the…”
    Get full text
    Journal Article
  20. 20

    Idebenone Prevents Oxidative Stress, Cell Death and Senescence of Retinal Pigment Epithelium Cells by Stabilizing BAX/Bcl-2 Ratio by Arend, Nicole, Wertheimer, Christian, Laubichler, Peter, Wolf, Armin, Kampik, Anselm, Kernt, Marcus

    Published in Ophthalmologica (Basel) (01-01-2015)
    “…Age-related macular degeneration (AMD) is one of the leading causes of blindness. Degeneration of the retinal pigment epithelium (RPE) is pathognomonic for the…”
    Get more information
    Journal Article